Animal study · rats
BPC-157 sped blood flow recovery in rats with hind limb ischemia
Checked against the paper Animal studyPublished by PepVault
The takeaway
This paper adds rat and lab evidence that BPC-157 can boost blood vessel growth and blood flow recovery, but it is not a result in humans.
- Kind
- Animal study
- Studied in
- Rats
- Published
- 2017
- Journal
- J Mol Med (Berl)
What they tested
The team set out to test whether BPC-157 helps new blood vessels form, and through which pathway it might work.
How the study was done
A preclinical study combining a chick chorioallantoic membrane test, a lab endothelial tube formation test, rats with hind limb ischemia (reduced blood flow to a hind leg), and lab-grown human vascular endothelial cells (cells that line blood vessels). Blood flow in the rats was tracked by laser Doppler scanning, and muscle tissue was checked under the microscope.

What they found
In rats with hind limb ischemia, BPC-157 made blood flow in the affected muscle recover faster, and the muscle held more vessels and more VEGFR2 (a receptor for a blood vessel growth factor). In the chick membrane test and in a lab endothelial tube formation test, a sign of new vessel growth, BPC-157 raised vessel density. In human vascular endothelial cells, it raised VEGFR2 at the mRNA and protein level but did not raise VEGF-A, and it drew VEGFR2 into the cell and switched on the VEGFR2-Akt-eNOS pathway over time. Dynasore, a drug that blocks endocytosis (the cell's uptake of material from its surface), stopped VEGFR2 from being drawn in, held back the pathway, and blocked the rise in tube formation.
What it doesn’t show
All results come from chick membranes, rats and lab-grown cells, so none of them show what BPC-157 does in people. The rat work looked at one type of leg blood flow injury and did not test other conditions.
The paper
Hsieh et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017.
The compound
More studies on BPC-157
- BPC-157: 10 of 12 women reported full interstitial cystitis reliefClinical trial · people · 2024
- BPC-157: 14 of 16 reported knee pain relief in a chart reviewObservational study · people · 2021
- BPC-157: non-significant tendon gains in rats; TB-500 did betterAnimal study · rats · 2026
- BPC-157 reduced leg muscle damage after ischemia-reperfusion in ratsAnimal study · rats · 2026
- BPC-157 closed duodenocolic fistulas in ratsAnimal study · rats · 2024
- BPC-157 limited isoprenaline-induced heart attack damage in ratsAnimal study · rats · 2022
- Every study on BPC-157
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.